Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)

Detailed price information for Novocure Ltd Ord Sh (NVCR-Q) from The Globe and Mail including charting and trades.